0001209191-13-034981.txt : 20130702
0001209191-13-034981.hdr.sgml : 20130702
20130702170607
ACCESSION NUMBER: 0001209191-13-034981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130702
FILED AS OF DATE: 20130702
DATE AS OF CHANGE: 20130702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383826477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1901 OLATHE BOULEVARD
CITY: KANSAS CITY
STATE: KS
ZIP: 66103
BUSINESS PHONE: 913.951.2130
MAIL ADDRESS:
STREET 1: 1901 OLATHE BOULEVARD
CITY: KANSAS CITY
STATE: KS
ZIP: 66103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GADICKE ANSBERT
CENTRAL INDEX KEY: 0001134655
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949601
MAIL ADDRESS:
STREET 1: THE JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAILIAN VAUGHN M
CENTRAL INDEX KEY: 0001180429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949600
MAIL ADDRESS:
STREET 1: P.O. BOX 70
CITY: BODEGA
STATE: CA
ZIP: 94922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scopa James Paul
CENTRAL INDEX KEY: 0001356950
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949604
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD
STREET 2: SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MPM BIOVENTURES V GP LLC
CENTRAL INDEX KEY: 0001482714
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949598
BUSINESS ADDRESS:
STREET 1: MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 425-9200
MAIL ADDRESS:
STREET 1: MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MPM BIOVENTURES V LLC
CENTRAL INDEX KEY: 0001482715
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949597
BUSINESS ADDRESS:
STREET 1: MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 425-9200
MAIL ADDRESS:
STREET 1: MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EVNIN LUKE
CENTRAL INDEX KEY: 0001134657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949603
MAIL ADDRESS:
STREET 1: THE JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET, 54TH STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MPM BIOVENTURES V, L.P.
CENTRAL INDEX KEY: 0001482716
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949605
BUSINESS ADDRESS:
STREET 1: MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 425-9200
MAIL ADDRESS:
STREET 1: MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foley Todd
CENTRAL INDEX KEY: 0001473930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949602
MAIL ADDRESS:
STREET 1: THE JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MPM ASSET MANAGEMENT INVESTORS BV5 LLC
CENTRAL INDEX KEY: 0001541412
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 13949599
BUSINESS ADDRESS:
STREET 1: C/O MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-425-9200
MAIL ADDRESS:
STREET 1: C/O MPM ASSET MANAGEMENT
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-07-02
0
0001509190
ARATANA THERAPEUTICS, INC.
PETX
0001482716
MPM BIOVENTURES V, L.P.
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001356950
Scopa James Paul
C/O MPM ASSET MANAGEMENT
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
0
0
1
0
0001134657
EVNIN LUKE
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001473930
Foley Todd
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001134655
GADICKE ANSBERT
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001180429
KAILIAN VAUGHN M
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001541412
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001482714
MPM BIOVENTURES V GP LLC
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001482715
MPM BIOVENTURES V LLC
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON
MA
02116
0
0
1
0
Common Stock
2013-07-02
4
C
0
2406739
A
2823173
I
See Footnote
Common Stock
2013-07-02
4
C
0
802246
A
3625419
I
See Footnote
Common Stock
2013-07-02
4
C
0
225631
A
3851050
I
See Footnote
Common Stock
2013-07-02
4
P
0
500000
6.00
A
4351050
I
See Footnote
Series A Preferred Stock
2013-07-02
4
C
0
4000000
0.00
D
Common Stock
2406739
0
I
See Footnote
Series B Preferred Stock
2013-07-02
4
C
0
1333333
0.00
D
Common Stock
802246
0
I
See Footnote
Series C Preferred Stock
2013-07-02
4
C
0
375000
0.00
D
Common Stock
225631
0
I
See Footnote
The shares are held as follows: 2,316,738 by MPM BioVentures V, L.P. ("BV V") and 90,001 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin, Vaughn M. Kailian, James Paul Scopa, Todd Foley and John Vander Vort are the members of BV LLC. Mr. Vander Vort is a director of the Issuer and has separately filed a Form 4. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.6016847 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date.
Immediately prior to the closing of the Issuer's initial public offering, the Issuer issued shares of its Common Stock to the holders of its Series A, B and C Preferred Stock in satisfaction of accumulated and unpaid dividends. Includes the following shares: 226,794 by BV V and 9,135 by AM BV5.
The shares are held as follows: 2,717,287 by BV V and 105,886 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares are held as follows: 772,246 by BV V and 30,000 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares are held as follows: 3,489,533 by BV V and 135,886 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares are held as follows: 217,194 by BV V and 8,437 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares are held as follows: 3,706,727 by BV V and 144,323 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares were purchased as follows: 481,302 by BV V and 18,698 by AM BV5.
The shares are held as follows: 4,188,029 by BV V and 163,021 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
The shares of Series A Preferred Stock were held as follows: 3,850,418 by BV V and 149,582 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective
pecuniary interest therein.
Immediately.
Not applicable.
The shares of Series B Preferred Stock were held as follows: 1,283,473 by BV V and 49,860 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective
pecuniary interest therein.
The shares of Series C Preferred Stock were held as follows: 360,977 by BV V and 14,023 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective
pecuniary interest therein.
By Ansbert Gadicke, member of MPM BioVentures V LLC, the managing member of MPM
BioVentures V GP LLC, the general partner of MPM BioVentures V, L.P. /s/ Ansbert Gadicke
2013-07-02
/s/ James Paul Scopa
2013-07-02
/s/ Luke Evnin
2013-07-02
/s/ Todd Foley
2013-07-02
/s/ Ansbert Gadicke
2013-07-02
/s/ Vaughn Kailian
2013-07-02
By Ansbert Gadicke, member of MPM BioVentures V LLC, the manager of MPM Asset Management Investors BV5 LLC /s/ Ansbert Gadicke
2013-07-02
By Ansbert Gadicke, member of MPM BioVentures V LLC, the managing member of MPM BioVentures V GP LLC /s/ Ansbert Gadicke
2013-07-02
By Ansbert Gadicke, member of MPM BioVentures V LLC /s/ Ansbert Gadicke
2013-07-02